Literature DB >> 17034392

Behavioral facilitation of medical treatment of headache: implications of noncompliance and strategies for improving adherence.

Jeanetta C Rains1, Donald B Penzien, Gay L Lipchik.   

Abstract

Clinical recommendations were gleaned from a review of treatment adherence published in the regular issue of Headache (released in tandem with this supplement). The recommendations include: (1) Nonadherence is prevalent among headache patients, undermines treatment efficacy, and should be considered as a treatment variable; (2) Calling patients to remind them of appointments and recalling those who miss a scheduled appointment are fundamentally the most cost-effective adherence-enhancing strategies, insofar as failed appointment-keeping acts as a ceiling on all future treatment and adherence efforts; (3) Simplified and tailored medication regimens improve adherence (eg, minimized number of medications and dosings, fixed-dose combinations, cue-dose training, stimulus control); (4) Screening and management of psychiatric comorbidities, especially depression and anxiety, is encouraged; (5) The concept of self-efficacy as a modifiable psychological process often can be employed to predict and improve adherence.

Entities:  

Mesh:

Year:  2006        PMID: 17034392     DOI: 10.1111/j.1526-4610.2006.00565.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  8 in total

1.  Focus group findings on the migraine patient experience during research studies and ideas for future investigations.

Authors:  Mia T Minen; Kaitlyn Morio; Kathryn Berlin Schaubhut; Scott W Powers; Richard B Lipton; Elizabeth Seng
Journal:  Cephalalgia       Date:  2019-12-23       Impact factor: 6.292

Review 2.  Barriers to Behavioral Treatment Adherence for Headache: An Examination of Attitudes, Beliefs, and Psychiatric Factors.

Authors:  Yuka Matsuzawa; Yuen Shan Christine Lee; Felicia Fraser; Donna Langenbahn; Amanda Shallcross; Scott Powers; Richard Lipton; Naomi Simon; Mia Minen
Journal:  Headache       Date:  2018-10-27       Impact factor: 5.887

3.  Factors Related to Migraine Patients' Decisions to Initiate Behavioral Migraine Treatment Following a Headache Specialist's Recommendation: A Prospective Observational Study.

Authors:  Mia T Minen; Sarah Azarchi; Rachel Sobolev; Amanda Shallcross; Audrey Halpern; Thomas Berk; Naomi M Simon; Scott Powers; Richard B Lipton; Elizabeth Seng
Journal:  Pain Med       Date:  2018-11-01       Impact factor: 3.750

Review 4.  Challenges of nonpharmacologic interventions in chronic tension-type headache.

Authors:  Todd A Smitherman; Donald B Penzien; Jeanetta C Rains
Journal:  Curr Pain Headache Rep       Date:  2007-12

5.  Using a graphical risk tool to examine willingness to take migraine prophylactic medications.

Authors:  Dana P Turner; Adrienne N Golding; Timothy T Houle
Journal:  Pain       Date:  2016-10       Impact factor: 7.926

6.  A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).

Authors:  Amaal J Starling; Stewart J Tepper; Michael J Marmura; Ejaz A Shamim; Matthew S Robbins; Nada Hindiyeh; Andrew C Charles; Peter J Goadsby; Richard B Lipton; Stephen D Silberstein; Amy A Gelfand; Richard P Chiacchierini; David W Dodick
Journal:  Cephalalgia       Date:  2018-03-04       Impact factor: 6.292

7.  A Prospective Observational Cohort Study on Pharmacological Habitus, Headache-Related Disability and Psychological Profile in Patients with Chronic Migraine Undergoing OnabotulinumtoxinA Prophylactic Treatment.

Authors:  Marialuisa Gandolfi; Valeria Donisi; Fabio Marchioretto; Simone Battista; Nicola Smania; Lidia Del Piccolo
Journal:  Toxins (Basel)       Date:  2019-08-29       Impact factor: 4.546

Review 8.  Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors.

Authors:  Donna Langenbahn; Yuka Matsuzawa; Yuen Shan Christine Lee; Felicia Fraser; Donald B Penzien; Naomi M Simon; Richard B Lipton; Mia T Minen
Journal:  J Gen Intern Med       Date:  2021-02-01       Impact factor: 5.128

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.